Hemodialysis Catheter-related Infections: Incidence, Microbiology and Outcome 5 years of Dubai Hospital Experience


  •   Hussein Yousif Salem

  •   Maseer Ahmed

  •   Kashif Gulzar

  •   Fakhriya Alalawi

  •   Amna Alhadari


Background: The central venous catheters (CVC) has recently become a worldwide commonest technique for vascular access, however; prone to infection and associated with other complications more than other vascular access techniques, such as fistula or graft.

Objective: To investigate the incidence, the types of micro-organism, the most sensitive and suitable antibiotics, the outcomes associated with CVC infection in chronic hemodialysis patients treated through tunneled CVC.in a single-center population.

Methods: The records of hemodialysis patients from January 2012 to December 2016 were reviewed. Patients above 14 years of age, on hemodialysis via a permanent tunneled catheter at any time of the mentioned period, were included. The rate of CRBSI (Catheter-Related Blood Stream Infections) was calculated as density of incidence and reported per 1000 catheter days. Patient mortality was recorded.

Results: In 5 years, a total of 73 episodes of CRBSI in 49 hemodialysis patients were recorded. 59.2% were male with a mean age of 53.57 years. 40.8% had end-stage kidney disease secondary to diabetic nephropathy. In all, 67.3% episodes grew Gram-positive isolates, among those staphylococci epidermidis (26.4%, n=19) and staphylococci aureus (25%, n=18) were the most common organism, whereas Klebsiella pneumonia (8.3%, n=6), Enterobacter cloacae (8.3%, n=6), pseudomonas aeruginosa (5.5%, n=4) and E.coli (5.5%, n=4) were the most common Gram-negative isolates. A total of 6 isolates were multidrug-resistant, which includes Klebsiella pneumonia, Citrobacter, and E. coli. Only 1 out of 18 staphylococci aureus cases were methicillin-resistant and 21% (n=6) of Gram-negative isolates were Extended-spectrum beta-lactamase (ESBL) producing organisms. The average hospital stay was 9 days (2-30 days). The hemodialysis catheter was removed for 19 (38.77%) patients and 4 (8.1%) patients expired due to septic shock despite catheter removal and being on appropriate antibiotics.

Conclusion: The mainstay to reduce CRBSI would be ideal to avoid catheters or decrease the duration of catheters. This can be achieved through more aggressive counseling and fast-track protocols for AV Fistulae creation at the pre-dialysis stage.

Keywords: Catheter-Related Blood Stream Infections (CRBSIs), Central Venous Catheters (CVC), End-Stage Renal Disease, Hemodialysis


Agarwal AK, Haddad NJ, Vachharajani TJ, Asif A. Innovations in vascular access for hemodialysis. Kidney Int. 2019 May;95(5):1053-63. doi: 10.1016/j.kint.2018.11.046.

Arhuidese IJ, Orandi BJ, Nejim B, Malas M. Utilization, patency, and complications associated with vascular access for hemodialysis in the United States. J Vasc Surg. 2018 Oct; 68(4):1166-74.

Allon M. Vascular access for hemodialysis patients: new data should guide decision making. Clin J Am Soc Nephrol. 2019 Jun 7;14(6):954-961. doi: 10.2215/CJN.00490119.

Rodríguez-Aranda A, Alcazar JM, Sanz F, et al. Endoluminal colonization as a risk factor for coagulase-negative staphylococcal catheter-related bloodstream infections in hemodialysis patients. Nephrol Dial Transplant 2011; 26(3): 948–955.

Gallieni M, Giordano A, Rossi U, Cariati M. Optimization of dialysis catheter function. J Vasc Access. 2016 Mar; 17 Suppl 1:S42-6.

Bohlke M, Uliano G, Barcellos FC. Hemodialysis catheter-related infection: prophylaxis, diagnosis and treatment. J Vasc Access. 2015 Sep-Oct;16(5):347-55.

McCann M, Einarsdottir H, Van Waeleghem JP, et al. Vascular access management III: central venous catheters. J Ren Care 2010; 36(1): 25–33.

Dittmer ID, Sharp D, McNulty CA, et al. A prospective study of central venous hemodialysis catheter colonization and peripheral bacteremia. Clin Nephrol 1999; 51: 34–39.

Johnson WJ, Kurtz SB, Mitchell JC, et al. Results of treatment of hemodialysis center patients. Mayo Clin Proc 1984; 59: 669–671.

Kovalik EC, Raymond JR, Albers FJ, et al. A clustering of epidural abscesses in chronic hemodialysis patients: risks of salvaging access catheters in cases of infection. J Am Soc Nephrol 1996; 7: 2264–2267.

Kaur M, Gupta V, Gombar S, Chander J, Sahoo T. Incidence, risk factors, microbiology of venous catheter associated bloodstream infections-a prospective study from a tertiary care hospital. Indian J Med Microbiol. 2015 Apr-Jun;33(2):248-54.

Napalkov P, Felici DM, Chu LK, et al. Incidence of catheter-related complications in patients with central venous or hemodialysis catheters: a health care claims database analysis. BMC Cardiovasc Disord 2013; 13: 86.

Taylor G, Gravel D, Johnston L, et al. Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 2002; 23: 716–720.

Gahlot R, Nigam C, Kumar V, et al. Catheter-related bloodstream infections. Int J Crit Illn Inj Sci 2014; 4(2): 162–167.

Ibrahim M, Fahad R.A, Sumaiya I, et al. Hemodialysis catheter-related infections: Result of tertiary care center study in Saudi Arabia. Int J Med Sci Public Health 2019;8(4): 318-25.

Amira M, Malik H.A, Khaled A.M, et al. Incidence of Central line associated blood stream infection in intensive care unit in private hospital (Cairo, Egypt). Open Publ Health J 2018; 11: 562-71.

Leonard A.M, Michael A, Emilio B, et al. Clinical practice guidelines for diagnosis and management of intravascular catheter related infection: 2009 update by infectious disease society of America. Clinical infectious disease 2009; 49(1): (1-45).

Haddadin Y, Annamaraju P, Regunath H. Central line associated blood stream infections (CLABSI). StatPearls [Internet]. 2020 Jun 22. Accessed on Jan 2021.

https://www.dbth.nhs.uk/wp-content/uploads/2017/12/CRBSI-final.pdf. Accessed on Jan 2021.

https://www.cdc.gov/infectioncontrol/pdf/guidelines/bsi-guidelines-H.pdf Accessed on Jan 2021.

Lok CE, Huber TS, Lee T, Shenoy S, Yevzlin AS, Abreo K, Allon M, Asif A, Astor BC, Glickman MH, Graham J. KDOQI clinical practice guideline for vascular access: 2019 update. American Journal of Kidney Diseases. 2020 Apr 1;75(4):S1-64.

Bolton WK. Renal Physicians Association Clinical Practice Guideline: Appropriate Patient Preparation for Renal Replacement Therapy: Guideline Number 3. Journal of the American Society of Nephrology. 2003 May 1;14(5):1406-10.

Vassalotti JA, Jennings WC, Beathard GA, Neumann M, Caponi S, Fox CH, et al. Fistula first breakthrough initiative: targeting catheter last in fistula first. Semin Dial. 2012;25(3):303–10.

de Pinho NA, Coscas R, Metzger M, Labeeuw M, Ayav C, Jacquelinet C, Massy ZA, Stengel B. Vascular access conversion and patient outcome after hemodialysis initiation with a nonfunctional arteriovenous access: a prospective registry-based study. BMC nephrology. 2017 Dec;18(1):1-1.

Malas MB, Canner JK, Hicks CW, Arhuidese IJ, Zarkowsky DS, Qazi U, et al. Trends in incident hemodialysis access and mortality. JAMA Surg. 2015;150(5):441–8.

Noordzij M, Jager KJ, van der Veer SN, Kramar R, Collart F, Heaf JG, et al. Use of vascular access for haemodialysis in Europe: a report from the ERA-EDTA Registry. Nephrol Dial Transplant. 2014;29(10):1956–64.

Allon M. Dialysis catheter-related bacteraemia: treatment and prophylaxis. Am J Kidney Dis 2004;44(5):779-91.

Lok CE, Mokrzycki MH. Prevention and management of catheter-related infection in haemodialysis patients. Kidney international. 2011;79(6):587-98.

Betjes MG. Prevention of catheter-related bloodstream infection in patients on haemodialysis. Nature reviews. Nephrology. 2011;7(5):257-65.

Shefali G, Shrikara P.M, Ashok B, Shrikala B. Microbiology of Non-tunneled catheter related infections. 2016;10(7):24-8.

Hao Y.Y, Shu C.P, Chei S.T, et al. Catheter related complications and survival among incident hemodialysis patients in Singapore. J Vasc Access. 201819(6):602-08.


How to Cite
Yousif Salem, H., Ahmed, M., Gulzar, K., Alalawi, F., & Alhadari, A. (2021). Hemodialysis Catheter-related Infections: Incidence, Microbiology and Outcome 5 years of Dubai Hospital Experience. European Journal of Clinical Medicine, 2(3), 111–115. https://doi.org/10.24018/clinicmed.2021.2.3.97

Most read articles by the same author(s)